The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden in a nationwide cohort.
 
McKayla J Riggs
Patents, Royalties, Other Intellectual Property - Patent pending
 
Nan Lin
No Relationships to Disclose
 
Rachel W. Miller
No Relationships to Disclose
 
Dava West Piecoro
Employment - Exelixis (I)
Stock and Other Ownership Interests - Exelixis (I)
 
Bryan P. Schneider
Honoraria - Lilly; Research to Practice
Research Funding - Exact Sciences; Foundation Medicine; Genentech/Roche; Pfizer
 
Hye Sook Chon
Honoraria - Curio Science; Main line health; MedSurvey
Consulting or Advisory Role - Envision Communications
 
John D. Carpten
Honoraria - Roche
Consulting or Advisory Role - Bristol Meyer Squibb; Roche/Genentech; Roche/Genentech
Patents, Royalties, Other Intellectual Property - Methods related to Precision Medicine Know-How.; Royalty for IP (USC 2018-116) from drug licensed by Bridgene Biosciences, Inc.
Other Relationship - M2Gen
 
Michelle L. Churchman
No Relationships to Disclose
 
Bradley Corr
Consulting or Advisory Role - AstraZeneca/Merck (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novocure (Inst)
Research Funding - Clovis Oncology (Inst)
 
Christina Washington
No Relationships to Disclose
 
Robert Dood
No Relationships to Disclose
 
Stephen B. Edge
Honoraria - North American Center for Continuing Medical Education; North American Center for Continuing Medical Education
Research Funding - Pfizer (Inst)
 
Aliza L. Leiser
No Relationships to Disclose
 
Erin M. Siegel
Research Funding - Bristol-Myers Squibb/Sanofi
 
Frederick West Ueland
No Relationships to Disclose
 
Jill Kolesar
Stock and Other Ownership Interests - Helix Diagnostics
Consulting or Advisory Role - The Jackson Laboratory
Research Funding - ArtemiLife
Patents, Royalties, Other Intellectual Property - Patent pending for a cell based therapy derived from human macrophages